Objective: Recent preclinical and clinical data suggest that thoracic epidural analgesia, a technique primarily aimed at decreasing pain, might exert anti-inflammatory effects, enhance splanchnic and pancreatic blood flow during acute pancreatitis; however, the influence of epidural analgesia on mortality remains under investigated in this setting. This study was therefore designed to assess the impact of epidural analgesia on mortality in ICU patients with acute pancreatitis. Design: Multicenter retrospective, observational, cohort study. Setting: Seventeen French and Belgian ICUs. Patients: All patients admitted to with acute pancreatitis between June 2009 and March 2014. Interventions: The primary exposure was thoracic epidural analgesia versus standard care without epidural analgesia. The primary outcome was 30-day mortality. Propensity analyses were used to control for bias in treatment assignment and prognostic imbalances. Measurements and Main Results: One thousand three ICU patients with acute pancreatitis were enrolled, of whom 212 died within 30 days. Epidural analgesia was used in 46 patients and was associated with reduced mortality in unadjusted analyses (4% vs. 22%; p = 0.003). After adjustment for baseline variables associated with mortality, epidural analgesia was still an independent predictor of 30-day mortality (adjusted odds ratio, 0.10; [95% CI, 0.02–0.49]; p = 0.004). Using propensity score analysis, the risk of all-cause 30-day mortality in patients with acute pancreatitis receiving epidural analgesia was significantly lower than that in matched patients who did not receive epidural analgesia (2% vs. 17%; p = 0.01). Conclusions: Among critically ill patients with acute pancreatitis, mortality at 30 days was lower in patients who received epidural analgesia than in comparable patients who did not. These findings support ongoing research on the use of epidural analgesia as a therapeutic intervention in acute pancreatitis. Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal’s website (http://ift.tt/29S62lw). Supported by institutional and/or departmental sources. Dr. Joannes-Boyau received funding from Baxter and BBraun. The remaining authors have disclosed that they do not have any potential conflicts of interest. For information regarding this article, E-mail: mjabaudon@chu-clermontferrand.fr Copyright © by 2017 by the Society of Critical Care Medicine and Wolters Kluwer Health, Inc. All Rights Reserved.
from Emergency Medicine via xlomafota13 on Inoreader http://ift.tt/2ANMVF5
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Abstract Haemonchus contortus is a highly pathogenic gastrointestinal nematode of small ruminant animals. In modern intensive farming, li...
-
Abstract Information on the viability of Toxoplasma gondii oocysts is crucial to establish the public health significance of this environ...
-
Abstract Purpose The effects of growth hormone (GH) treatment on linear growth and body composition have been studied extensively. Littl...
-
Abstract Background and Objectives Suvorexant is an orexin receptor antagonist indicated for the treatment of insomnia, characterized by...
-
Abstract The flow of information between different regions of the cortex is fundamental for brain function. Researchers use causality dete...
-
Most recent California wildfires have killed at least 29 people and destroyed more than 6,400 homes from EMS via xlomafota13 on Inoreader ...
-
Abstract Purpose This study examined the effect of different knee flexion angles with a constant hip and knee torque on the muscle force...
-
Note: Page numbers of article titles are in boldface type. from Emergency Medicine via xlomafota13 on Inoreader http://ift.tt/2p9V0xt
-
Objective: Cerebrovascular reactivity can provide a continuously updated individualized target for management of cerebral perfusion pressur...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου